← Insider buys
KRTX

Karuna Therapeutics, Inc.

Chief Medical Officer Stephen K. Brannan sold $1.6M of Karuna Therapeutics, Inc.

Sold$1,580,667
$316.13Price
5,000Shares
−11%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Thu, Feb 8. Filed Mon, Feb 12, 12:09 PM ET, during the session. Not investment advice.